ZS Pharma (ZSPH) Reports Interim Results From Long-Term Safety Study of ZS-9
Tweet Send to a Friend
ZS Pharma, Inc. (Nasdaq: ZSPH) presented interim results from ZS005, a long-term safety and efficacy study of ZS-9 (sodium zirconium ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
